Cel
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease. BLUEPRINT will focus on distinct types of haematopoietic cells from healthy individuals and on their malignant leukaemic counterparts. Reference epigenomes will be generated by state-of-the-art technologies from highly purified cells for a comprehensive set of epigenetic marks in accordance with quality standards set by IHEC. This resource-generating activity will be conducted at dedicated centres to be complemented by confederated hypothesis-driven research into blood-based diseases, including common leukaemias and autoimmune disease (T1D), by epigenetic targets and compound identification, and by discovery and validation of epigenetic markers for diagnostic use. By focussing on 100 samples of known genetic variation BLUEPRINT will complete an epigenome-wide association study, maximizing the biomedical relevance of the reference epigenomes. Key to the success of BLUEPRINT will be the integration with other data sources (i.e. ICGC, 1000 genomes and ENCODE), comprehensive bioinformatic analysis, and user-friendly dissemination to the wider scientific community. The involvement of innovative companies will energize epigenomic research in the private sector by creating new targets for compounds and the development of smart technologies for better diagnostic tests. BLUEPRINT will outreach through a network of associated members and form critical alliances with leading networks in genomics and epigenomics within Europe and worldwide. Through its interdisciplinarity and scientific excellence combined with its strong commitment to networking, training and communication BLUEPRINT strives to become the cornerstone of the EU contribution to IHEC.
Dziedzina nauki
Zaproszenie do składania wniosków
FP7-HEALTH-2011-single-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
6525 XZ Nijmegen
Niderlandy
Zobacz na mapie
Uczestnicy (44)
WC1E 6BT London
Zobacz na mapie
CB2 1TN Cambridge
Zobacz na mapie
4058 BASEL
Zobacz na mapie
24118 Kiel
Zobacz na mapie
28029 Madrid
Zobacz na mapie
20121 Milano
Zobacz na mapie
69117 Heidelberg
Zobacz na mapie
CB10 1SA SAFFRON WALDEN
Zobacz na mapie
08908 L'Hospitalet De Llobregat
Zobacz na mapie
08028 Barcelona
Zobacz na mapie
80539 Munchen
Zobacz na mapie
66123 Saarbrucken
Zobacz na mapie
81100 Caserta
Zobacz na mapie
08003 Barcelona
Zobacz na mapie
E1 4NS London
Zobacz na mapie
CB22 3AT Cambridge
Zobacz na mapie
69117 Heidelberg
Zobacz na mapie
Zakończenie uczestnictwa
69117 HEIDELBERG
Zobacz na mapie
4102 Seraing
Zobacz na mapie
Zakończenie uczestnictwa
75183 Uppsala
Zobacz na mapie
Zakończenie uczestnictwa
SE16494 KISTA
Zobacz na mapie
80335 Muenchen
Zobacz na mapie
OX4 4GA Oxford
Zobacz na mapie
Zakończenie uczestnictwa
53100 SIENA
Zobacz na mapie
75654 Paris
Zobacz na mapie
08036 Barcelona
Zobacz na mapie
7610001 Rehovot
Zobacz na mapie
3015 GD Rotterdam
Zobacz na mapie
89081 Ulm
Zobacz na mapie
EH8 9YL Edinburgh
Zobacz na mapie
22100 Lund
Zobacz na mapie
1165 Kobenhavn
Zobacz na mapie
00185 Roma
Zobacz na mapie
Zakończenie uczestnictwa
28760 TRES CANTOS MADRID
Zobacz na mapie
1211 Geneve
Zobacz na mapie
9713 GZ Groningen
Zobacz na mapie
75794 Paris
Zobacz na mapie
45147 Essen
Zobacz na mapie
04109 Leipzig
Zobacz na mapie
08034 Barcelona
Zobacz na mapie
Zakończenie uczestnictwa
756 51 UPPSALA
Zobacz na mapie
66386 St Ingbert
Zobacz na mapie
1090 Wien
Zobacz na mapie
4056 BASEL
Zobacz na mapie